Antibodies targeting Mycobacterium tuberculosis peptides inhibit mycobacterial entry to infection target cells

Mary L. Carabali-Isajar, Marisol Ocampo, Yahson Varela, Diana Díaz-Arévalo, Manuel A. Patarroyo, Manuel E. Patarroyo

Research output: Contribution to journalResearch Articlepeer-review

4 Scopus citations


The humoral immunity regarding tuberculosis can contribute towards controlling the mycobacteria and the disease. Antigens mediating such type of immunity should thus be evaluated for formulating anti-tuberculosis vaccines. The antigen recognition of seven peptides derived from proteins on Mtb H37Rv envelope and a further seven peptides modified from them was evaluated in sera taken from people suffering Mtb infection and others free from it. Peptide sequences' ability to inhibit Mtb entry to human macrophages was determined in vitro and, after isolating peptide-specific IgG antibodies, it was ascertained which ones were exercising such inhibitory function. Aotus were inoculated with the modified peptides for evaluating the activity of the antibodies so produced. Human QTF+ and QTF- sera recognised some of the peptides and inhibited Mtb entry. The same effect was seen with peptide-specific IgG regarding all the native sequences and modified ones. Sera taken from inoculated Aotus was also able to reduce the pathogen's entry. The data showed that some peptides evaluated in this study could induce antibodies able to inhibit the pathogen's entry to human macrophages, i.e. they could represent candidates for part of an anti-tuberculosis vaccine. The methodology used here complements the evaluation of promising antigens for designing effective vaccines.

Original languageEnglish (US)
Pages (from-to)712-720
Number of pages9
JournalInternational Journal of Biological Macromolecules
StatePublished - Oct 15 2020

All Science Journal Classification (ASJC) codes

  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Economics and Econometrics
  • General Energy


Dive into the research topics of 'Antibodies targeting Mycobacterium tuberculosis peptides inhibit mycobacterial entry to infection target cells'. Together they form a unique fingerprint.

Cite this